SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGGI (IGG International)with 5.25Billion market?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rocket who wrote (94)1/16/1998 9:45:00 AM
From: Redhead  Read Replies (1) of 96
 
To all,

Friday January 16, 8:59 am Eastern Time
Company Press Release
SOURCE: IGG International, Inc.
IGG International Changes Corporate Name to SafeScience, Inc.
Company Launches World Brand Based on "Responsible Science"
BOSTON, Jan. 16 /PRNewswire/ -- IGG International, Inc. (Nasdaq: IGGI - news) today announced that the Company has adopted a new name and new stock trading symbol -- SafeScience, Inc. (Nasdaq: SAFS - news). The new name and trading symbol became effective today, January 16, 1998.

In addition, ''SafeScience'' has been cleared as a worldwide trademark and the Company is formalizing registration in all major markets. The SafeScience(TM) trademark reflects the Company's commitment to setting new standards for ''responsible science''. That is, science which poses no threat to human health or the environment. The Company is developing and marketing safe, effective, naturally-derived agricultural and pharmaceutical products.

''We have created the word SafeScience(TM) because there is no single word that defines technology which is safe for both humans and their environment,'' stated Bradley J. Carver, President of SafeScience, Inc. ''In the area of agriculture, the worldwide markets for alternatives to synthetic chemical fungicides, insecticides and fertilizers are rapidly growing. Our SafeScience(TM) products represent a whole new set of options to conventional agricultural products and technologies.''

''Safety without jeopardizing effectiveness is the most important characteristic of our newly launched agricultural fungicides and fertilizers,'' stated Richard Salter, Senior Vice President of Business Development. ''We recently signed the first SafeScience(TM) distribution agreements for Australia, New Zealand, the United Arab Emirates and the Kingdom of Saudi Arabia. These agreements, coupled with the recent Environmental Protection Agency (EPA) marketing approval of our naturally-derived fungicide, ELEXA(TM) (November 1997), represent important milestones for the Company. These distribution agreements affirm the growing worldwide demand for safer, healthier food and a cleaner environment. The Company is now looking to establish additional alliances, under the banner of SafeScience(TM), in order to further its global presence.''

SafeScience, Inc. is developing a portfolio of agricultural and pharmaceutical products to replace conventional treatments employing synthetic chemicals. The Company's products are primarily based on the chemistry of complex carbohydrate compounds. Beyond the Company's agricultural products, its human therapeutic products include a carbohydrate compound to treat cancer, which is in human clinical trials, as well as an antifungal compound.

The Company recently relocated and expanded its headquarters to 31 St. James Avenue, Boston, MA 02116. All phone and fax numbers remain the same. Further information is available on SafeScience's website: www.safesci.com.

Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, risks of product nonapproval or delays by the EPA or foreign regulatory authorities, product development and market acceptance risks, the impact of competitive products and pricing, the results of current and future licensing and other collaborative relationships, the results of financing efforts, developments regarding intellectual property rights and litigation, and other risks identified in the Company's Securities and Exchange Commission filings. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward-looking statements, which speak only as the date hereof. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

SOURCE: IGG International, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext